Heart risk under the microscope: new diabetes study in southeast asia
NCT ID NCT07532863
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study reviews medical records of 400 adults aged 40-70 who were recently diagnosed with type 2 diabetes in five Southeast Asian countries. Researchers will look at health data from before and after diagnosis to understand how heart disease risk is distributed. No new treatments are given; the goal is to gather information to improve future care.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this study could help doctors better identify and manage heart disease risk early in people with new type 2 diabetes in Southeast Asia.
What could go wrong
This is an observational study that only looks back at existing records, so it cannot prove cause and effect. Results may not apply to other regions or populations.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS (TYPE 2) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
National Heart Institute
NOT_YET_RECRUITINGKuala Lumpur, 50400, Malaysia
-
Novo Nordisk Investigational Site
RECRUITINGSingapore, Singapore
-
Siloam Hospitals Lippo Village
NOT_YET_RECRUITINGTangerang, Banten, 15810, Indonesia
-
Siloam Hospitals Surabaya
ENROLLING_BY_INVITATIONSurabaya, East Java, 60281, Indonesia
-
The Medical City Ortigas
NOT_YET_RECRUITINGPasig, National Capital Region, 1800, Philippines
-
University Malaya Medical Centre
ENROLLING_BY_INVITATIONLembah Pantai, Kuala Lumpur, 59100, Malaysia